NYC Jury Hands Woman Malpractice MegaMillions


The verdict is out and it could make one woman wealthy beyond belief

A New York City jury is forcing three separate hospitals – Jacobi Medical Center (Bronx), Kings County Medical Center (Brooklyn) and the Brookdale University Hospital and Medical Center (Jersey) – to pay a grand total of $120 million to a 45-year-old woman named Jacqueline Martin. According to the New York Times, the verdict’s payment is one of the largest malpractice amounts ever sued for and issued in the state’s history.
So what happened?
In 2004, Martin suffered a seizure and was taken to the three separate sites for diagnosis and treatment. After management mess-ups and faulty medications, the New York City woman developed a rare skin disorder called Steven-Johnsons Syndrome and began to experience brain damage due to it. Soon after, Martin’s mother was forced to file a lawsuit against the three establishments, which eventually found itself in the state Supreme Court.

And the jury definitely listened.

The $120 million payment will be split four ways: 50 percent tied to Jacobi Medical Center ($60 million), 40 percent goes to Kings County Medical Center ($30 million), 5 percent on Brookdale ($6 million) and 4 percent to Martin’s team of neurologists ($4.8 million). As you can see, there’s more than enough blame to go around.

However, the City’s Health and Hospitals Corporation is not accepting defeat just yet and plans to appeal, spotting deficits in the jury’s decisions.
For example, Martin made less than $40,000 a year before she was ill and her payment in lost earnings was $10 million; her Medicaid tab was around $500,000 and she got handed $5 million. The Corporation’s deputy counsel, Suzanne Bundi, made this point when she said “the amount of this judgment is not consistent with the facts and the law.”
If the city is granted its appeal, a huge amount of money could be on the line in a case that affects a whole slew of parties. Runnin’ Scared will keep you updated if this story progresses any further.